Department of Radiation Oncology, University Hospital Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590, Frankfurt, Germany.
Institut of Biostatistics and Mathematical Modeling, Goethe University, Frankfurt am Main, Germany.
Strahlenther Onkol. 2018 Aug;194(8):750-758. doi: 10.1007/s00066-018-1308-0. Epub 2018 May 14.
Due to the absence of randomized trials, the optimal management for squamous cell cancer of unknown primary in the head and neck region (SCCHN CUP) remains controversial. Current strategies are based on retrospective studies, clinical experience, and institutional policies.
An anonymous questionnaire with a total of 24 questions was created and distributed by the use of an online version (Google Forms®, Google, Mountain View, CA, USA) as well as a printout version as equivalent option. An email with a link to the survey and the questionnaire as attachment was sent to 361 DEGRO(German Society of Radiation Oncology)-associated departments. Frequency distributions of responses for each question were calculated. The data were also analyzed by type of practice. Representativity of the sample size for the DEGRO was also evaluated.
66 responses were received including answers from 20 (30%) university departments, 16 (24%) non-university institutions, and 30 (46%) radiation oncology practices. 95% of the participants routinely present these cases in an interdisciplinary tumor board and use intensity modulated radiotherapy (IMRT) techniques for SCCHN CUP treatment. Surgery includes neck dissection in 83% and tonsillectomy in 73% of the cases. Human papilloma virus (HPV) status is routinely determined in 82% of the departments. Statistically significant differences between universities and institutions and clinics and practices could be found with respect to positron emission tomography-computed tomography (PET-CT) utilization, indications for chemotherapy, radiotherapy volumes, and cumulative doses.
Diagnostics and treatment for SCCHN CUP within the DEGRO remain heterogeneous. A prospective register trial with standard operation procedures is warranted to homogenize and possibly improve management.
由于缺乏随机试验,头颈部不明原发鳞状细胞癌(SCCHN CUP)的最佳治疗方案仍存在争议。目前的治疗策略基于回顾性研究、临床经验和机构政策。
采用在线版(Google Forms®,Google,Mountain View,CA,USA)和打印版作为等效选项,创建了一份包含 24 个问题的匿名问卷,并通过电子邮件将带有调查链接和问卷附件的电子邮件发送给 361 个 DEGRO(德国放射肿瘤学会)相关部门。计算了每个问题的回答频率分布。还根据实践类型分析了数据。还评估了 DEGRO 样本量的代表性。
共收到 66 份回复,包括 20 个(30%)大学部门、16 个(24%)非大学机构和 30 个(46%)放射肿瘤学实践的回复。95%的参与者通常在多学科肿瘤委员会中提出这些病例,并使用调强放疗(IMRT)技术治疗 SCCHN CUP。手术包括 83%的颈部清扫术和 73%的扁桃体切除术。82%的科室常规确定人乳头瘤病毒(HPV)状态。在正电子发射断层扫描-计算机断层扫描(PET-CT)的使用、化疗指征、放疗体积和累积剂量方面,大学和机构与诊所和实践之间存在统计学显著差异。
DEGRO 内的 SCCHN CUP 诊断和治疗仍然存在异质性。需要进行具有标准操作程序的前瞻性登记试验,以实现同质化并可能改善治疗效果。